sfgh orthopaedic trauma institute

San Francisco General Hospital (SFGH)

Upcoming Trials

A Phase 2/3, Multicenter, Double-Blind, Randomized, Controlled Study of Recombinant Human Bone Morphogenetic Protein-2 (rhBMP-2)/Calcium Phosphate Matrix (CPM) in Closed Diaphyseal Tibial Fractures

Sponsor: Wyeth Research

 

OP-1 Tibial IntraMedullary nail Assessment of the Lower extremity

Sponsor: Stryker Biotech

 

Fluid Irrigation Techniques in Patients with Open Fracture Wounds: A Multi-Center Blinded Randomized Controlled Trial

Sponsor: Physician Services Incorporated Foundation